MedTrace Logo

Chinese PD-GBA Registry

NCT03523065 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2018-05-29

No results posted yet for this study

Summary

The purpose of the Chinese Parkinson's disease with GBA variants Registry (CPD-GBAR) is to develop a database of patients of Parkinson's disease with Glucocerebrosidase (GBA) gene variants in mainland China.

Conditions

  • Parkinson Disease

Sponsors & Collaborators

  • Xiangya Hospital of Central South University

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-01
Primary Completion
2027-02-01
Completion
2027-02-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03523065 on ClinicalTrials.gov